Lindbergh, Cutter A. Dishman, Rodney K. and Miller, L. Stephen 2016. Functional Disability in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. Neuropsychology Review, Vol. 26, Issue. 2, p. 129.
Tsai, Chia-Liang Pai, Ming-Chyi Ukropec, Jozef and Ukropcová, Barbara 2016. The Role of Physical Fitness in the Neurocognitive Performance of Task Switching in Older Persons with Mild Cognitive Impairment. Journal of Alzheimer's Disease, Vol. 53, Issue. 1, p. 143.
Hatz, Florian Hardmeier, Martin Benz, Nina Ehrensperger, Michael Gschwandtner, Ute Rüegg, Stephan Schindler, Christian Monsch, Andreas U. and Fuhr, Peter 2015. Microstate connectivity alterations in patients with early Alzheimer’s disease. Alzheimer's Research & Therapy, Vol. 7, Issue. 1,
Jiang, Shixiang Qu, Changda Wang, Fengjun Liu, Yupeng Qiao, Zhengxue Qiu, Xiaohui Yang, Xiuxian and Yang, Yanjie 2015. Using event-related potential P300 as an electrophysiological marker for differential diagnosis and to predict the progression of mild cognitive impairment: a meta-analysis. Neurological Sciences, Vol. 36, Issue. 7, p. 1105.
Migo, E.M. Mitterschiffthaler, M. O’Daly, O. Dawson, G.R. Dourish, C.T. Craig, K.J. Simmons, A. Wilcock, G.K. McCulloch, E. Jackson, S.H.D. Kopelman, M.D. Williams, S.C.R. and Morris, R.G. 2015. Alterations in working memory networks in amnestic mild cognitive impairment. Aging, Neuropsychology, and Cognition, Vol. 22, Issue. 1, p. 106.
Nordlund, Arto Berggren, Jens Holmström, Alexandra Fu, Michael and Wallin, Anders 2015. Frequent Mild Cognitive Deficits in Several Functional Domains in Elderly Patients With Heart Failure Without Known Cognitive Disorders. Journal of Cardiac Failure, Vol. 21, Issue. 9, p. 702.
Yilmaz, U. 2015. Alzheimer-Demenz. Der Radiologe, Vol. 55, Issue. 5, p. 386.
Ascaso, Francisco J. Cruz, Nancy Modrego, Pedro J. Lopez-Anton, Raul Santabárbara, Javier Pascual, Luis F. Lobo, Antonio and Cristóbal, José A. 2014. Retinal alterations in mild cognitive impairment and Alzheimer’s disease: an optical coherence tomography study. Journal of Neurology, Vol. 261, Issue. 8, p. 1522.
Benz, Nina Hatz, Florian Bousleiman, Habib Ehrensperger, Michael M. Gschwandtner, Ute Hardmeier, Martin Ruegg, Stephan Schindler, Christian Zimmermann, Ronan Monsch, Andreas Urs and Fuhr, Peter 2014. Slowing of EEG Background Activity in Parkinsonâ€™s and Alzheimerâ€™s Disease with Early Cognitive Dysfunction. Frontiers in Aging Neuroscience, Vol. 6,
Boksha, Irina S. Gavrilova, Svetlana I. Kolykhalov, Igor V. Fedorova, Iana B. Kalyn, Iaroslav B. Selezneva, Natalia D. Samorodov, Andrei V. Miasoedov, Serge N. and Mukaetova-Ladinska, Elizabeta B. 2014. Progression of Cognitive Deficit in Older People with Mild Cognitive Impairment Treated with Cerebrolysin. Health, Vol. 06, Issue. 19, p. 2581.
Gavrilova, S. I. Kolykhalov, I. V. Fedorova, Ya. B. Kalyn, Ya. B. Selezneva, N. D. Samorodov, A. V. Myasoedov, S. N. and Boksha, I. S. 2014. Prognosis of Progressive Cognitive Deficit in Elderly Patients with Mild Cognitive Impairment Receiving Long-Term Treatment (3-year observations). Neuroscience and Behavioral Physiology, Vol. 44, Issue. 6, p. 631.
Leoutsakos, Jeannie-Marie S. Bartlett, Alexandra L. Forrester, Sarah N. and Lyketsos, Constantine G. 2014. Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: Conceptual framework and example. Alzheimer's & Dementia, Vol. 10, Issue. 2, p. 152.
Turana, Yuda Ranakusuma, Teguh Asaat S. Purba, Jan Sudir Amir, Nurmiati Ahmad, Siti Airiza Machfoed, Moh. Hasan Handayani, Yvonne Suzy Asmarinah, and Waspadji, Sarwono 2014. Enhancing Diagnostic Accuracy of aMCI in the Elderly: Combination of Olfactory Test, Pupillary Response Test, BDNF Plasma Level, and APOE Genotype. International Journal of Alzheimer's Disease, Vol. 2014, p. 1.
Kaerst, Lisa Kuhlmann, Andre Wedekind, Dirk Stoeck, Katharina Lange, Peter and Zerr, Inga 2013. Cerebrospinal fluid biomarkers in Alzheimer’s disease, vascular dementia and ischemic stroke patients: a critical analysis. Journal of Neurology, Vol. 260, Issue. 11, p. 2722.
Dosunmu, Remi Alashwal, Hany and Zawia, Nasser H. 2012. Genome-wide expression and methylation profiling in the aged rodent brain due to early-life Pb exposure and its relevance to aging. Mechanisms of Ageing and Development, Vol. 133, Issue. 6, p. 435.
Godinho, Cláudia Camozzato, Ana Luiza Onyszko, Diego and Chaves, Márcia Lorena 2012. Estimation of the risk of conversion of mild cognitive impairment of Alzheimer type to Alzheimer's disease in a south Brazilian population-based elderly cohort: the PALA study. International Psychogeriatrics, Vol. 24, Issue. 04, p. 674.
Peters, Oliver Lorenz, D. Fesche, A. Schmidtke, K. Hüll, M. Perneczky, R. Rüther, E. Möller, H. -J. Jessen, F. Maier, W. Kornhuber, J. Jahn, H. Luckhaus, C. Gertz, H. -J. Schröder, J. Pantel, J. Teipel, S. Wellek, S. Frölich, L. and Heuser, I. 2012. A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI. The journal of nutrition, health & aging, Vol. 16, Issue. 6, p. 544.
Teixeira, Camila Vieira Ligo Gobbi, Lilian Teresa Bucken Corazza, Danilla Icassatti Stella, Florindo Costa, José Luiz Riani and Gobbi, Sebastião 2012. Non-pharmacological interventions on cognitive functions in older people with mild cognitive impairment (MCI). Archives of Gerontology and Geriatrics, Vol. 54, Issue. 1, p. 175.
Choi, Jihye Lee, Ho-Won and Suk, Kyoungho 2011. Increased plasma levels of lipocalin 2 in mild cognitive impairment. Journal of the Neurological Sciences, Vol. 305, Issue. 1-2, p. 28.
Duara, Ranjan Loewenstein, David A. Potter, Elizabeth Barker, Warren Raj, Ashok Schoenberg, Michael Wu, Yougui Banko, Jessica Potter, Huntington Greig, Maria T. Schinka, John and Borenstein, Amy 2011. Pre-MCI and MCI: Neuropsychological, Clinical, and Imaging Features and Progression Rates. The American Journal of Geriatric Psychiatry, Vol. 19, Issue. 11, p. 951.
Background: A large proportion of patients with amnestic mild cognitive impairment (MCI) progress to Alzheimer's disease (AD), but the rate of conversion is highly variable, depending on selection and inclusion criteria. In the present prospective study, amnestic MCI criteria were applied in order to enrich the study population with prodromal AD patients.
Methods: A composite CERAD word list learning z-score of −1 was applied as a cut-off for memory performance at baseline. Competing causes of memory impairment other than prodromal AD were actively excluded. A cohort of 88 amnestic MCI patients was included; 75 were available for follow-up.
Results: After a mean delay of 19 months, 44% were found to have converted to AD, corresponding to an annualized conversion rate of 28%. The rate of new diagnoses other than stable MCI or AD was 6%. Baseline neuropsychological variables were not instrumental to predict progression.
Conclusion: Amnestic MCI patients, as identified by the present set of criteria, carry a high risk of median-term progression to AD.
This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.